Caption Management, LLC Amarin Corp Plcuk Call Options Transaction History

Caption Management, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 16, 2021	SELL	$4.26 - $6.5 $2.47 Million - $3.77 Million	-579,300 Reduced 88.54%	75,000 $328,000
Q1 2021 May 17, 2021	SELL	$5.03 - $8.8 $5.31 Million - $9.29 Million	-1,055,600 Reduced 61.73%	654,300 $4.06 Million
Q1 2020 May 15, 2020	BUY	$4.0 - $21.53 $4.26 Million - $22.9 Million	1,064,900 Added 165.1%	1,709,900 $6.84 Million
Q4 2019 Feb 13, 2020	BUY	$13.94 - $24.12 $1.17 Million - $2.02 Million	83,700 Added 14.91%	645,000 $13.8 Million
Q3 2019 Nov 14, 2019	BUY	$13.89 - $23.16 $4.91 Million - $8.19 Million	353,800 Added 170.51%	561,300 $8.51 Million
Q2 2019 Aug 13, 2019	SELL	$16.27 - $20.51 $2.68 Million - $3.38 Million	-165,000 Reduced 44.3%	207,500 $4.02 Million
Q1 2019 May 14, 2019	SELL	$12.61 - $22.33 $3.18 Million - $5.63 Million	-252,200 Reduced 40.37%	372,500 $7.73 Million
Q4 2018 Jan 30, 2019	BUY	$12.41 - $22.98 $2.79 Million - $5.16 Million	224,700 Added 56.18%	624,700 $8.5 Million
Q3 2018 Nov 14, 2018	BUY	$2.45 - $16.27 $980,000 - $6.51 Million	400,000 New	400,000 $6.51 Million

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.